Literature DB >> 19034699

Bowel ischemia: a rare complication of thiopental treatment for status epilepticus.

Carlo Cereda1, Mette M Berger, Andrea O Rossetti.   

Abstract

BACKGROUND: Refractory status epilepticus (RSE) treatment is usually performed with coma induction using an appropriate general anesthetic. Most frequent complications are represented by hypotension and infection. Other side-effects may however be encountered. OBSERVATIONS: We describe two patients suffering from acute bowel ischemia after thiopental (THP) treatment for RSE. A 73-year-old man with a complex-patial RSE following an acute stroke received THP (303 mg/kg over 48 h); 36 h after THP discontinuation, he presented abdominal tenderness and lactate elevation. Necrosis of the terminal ileum and colon was seen during surgical exploration; he deceased shortly thereafter. A 21 year-old woman had a cryptogenic de novo generalized-convulsive RSE resistant to 5 attempts of EEG burst-suppression. During the 6th attempt, after THP (840 mg/kg over 150 h) together with mild hypothermia, she developed an ileus with elevated serum lactate; caecum necrosis was observed during surgery. Hypernatremia, acidosis and hyperlactatemia heralded this complication in both patients.
CONCLUSION: In these two patients, mechanical vascular ischemia may have resulted from drug-induced paralytic ileus. To our knowledge, this is the first report describing this potential fatal side effect in adults with RSE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034699     DOI: 10.1007/s12028-008-9168-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  17 in total

1.  A "malignant" variant of status epilepticus.

Authors:  Martin Holtkamp; Jalal Othman; Katharina Buchheim; Florian Masuhr; Eva Schielke; Hartmut Meierkord
Journal:  Arch Neurol       Date:  2005-09

Review 2.  The management of refractory status epilepticus: an update.

Authors:  Daniel H Lowenstein
Journal:  Epilepsia       Date:  2006       Impact factor: 5.864

3.  Very-high-dose phenobarbital for childhood refractory status epilepticus.

Authors:  Wai Kin Lee; Kam Tim Liu; Betty Wan Yin Young
Journal:  Pediatr Neurol       Date:  2006-01       Impact factor: 3.372

Review 4.  Which anesthetic should be used in the treatment of refractory status epilepticus?

Authors:  Andrea O Rossetti
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

5.  High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury.

Authors:  H M Eisenberg; R F Frankowski; C F Contant; L F Marshall; M D Walker
Journal:  J Neurosurg       Date:  1988-07       Impact factor: 5.115

6.  Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus.

Authors:  Elena L Zarovnaya; Barbara C Jobst; Brent T Harris
Journal:  Epilepsia       Date:  2007-03-22       Impact factor: 5.864

7.  Intestinal infarction complicating phenobarbital overdose.

Authors:  K R Olson; S M Pond; E D Verrier; M Federle
Journal:  Arch Intern Med       Date:  1984-02

Review 8.  Non-occlusive mesenteric ischaemia: a common disorder in gastroenterology and intensive care.

Authors:  Jeroen J Kolkman; Peter B F Mensink
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-06       Impact factor: 3.043

9.  Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin.

Authors:  P C Van Ness
Journal:  Epilepsia       Date:  1990 Jan-Feb       Impact factor: 5.864

10.  High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit.

Authors:  I Parviainen; A Uusaro; R Kälviäinen; E Kaukanen; E Mervaala; E Ruokonen
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

View more
  12 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  A randomized trial for the treatment of refractory status epilepticus.

Authors:  Andrea O Rossetti; Tracey A Milligan; Serge Vulliémoz; Costas Michaelides; Manuel Bertschi; Jong Woo Lee
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

3.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

4.  Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.

Authors:  Annalena Hottinger; Raoul Sutter; Stephan Marsch; Stephan Rüegg
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

Review 5.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

6.  Treatment options in the management of status epilepticus.

Authors:  Andrea O Rossetti
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

Review 7.  Bowel Ischemia in Refractory Status Epilepticus: Report of Two Cases and Review of the Literature.

Authors:  P Rizek; K M Ikeda; T Mele; B Garcia; T E Gofton
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 8.  Systemic Complications Following Status Epilepticus.

Authors:  Maximiliano A Hawkes; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-07       Impact factor: 5.081

Review 9.  Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS.

Authors:  Stephane Legriel; Fernando Pico; Yves-Roger Tran-Dinh; Virginie Lemiale; Jean-Pierre Bedos; Matthieu Resche-Rigon; Alain Cariou
Journal:  Ann Intensive Care       Date:  2016-06-21       Impact factor: 6.925

Review 10.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.